Free shipping on all orders over $ 500

IDE397

Cat. No. M55363

All AbMole products are for research use only, cannot be used for human consumption.

IDE397 Structure
Synonym:

GSK-4362676; MAT2A-IN-9

Size Price Availability Quantity
5mg USD 350  USD350 In stock
10mg USD 530  USD530 In stock
25mg USD 860  USD860 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

IDE397 (GSK-4362676) is a potent, potential "first-in-class" inhibitor of methionine adenosyltransferase 2A (MAT2A). IDE397 (GSK-4362676) exhibits anti-tumor activity in MTAP-deleted PDX models.

Chemical Information
Molecular Weight 340.69
Formula C14H8ClF3N4O
CAS Number 2439277-80-0
Solubility (25°C) DMSO 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related Methionine Adenosyltransferase Products
MAT2A-IN-10

MAT2A-IN-10 is an orally active MAT2A inhibitor with an IC50 of 26 nM.

MAT2A-IN-12

MAT2A Allosteric inhibitor 2 is a potent and selective MAT2A allosteric inhibitor with an IC50 of 5 nM.

MAT2A inhibitor 3 

MAT2A inhibitor 3 is a methionine adenosyltransferase 2A (MAT2A) inhibitor, with an IC50 of <200 nM. MAT2A inhibitor 3 can be used for the research of cancers.

MAT2A inhibitor 2 

MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor.

AG-270

AG-270 is a non-competitive, first-of-its-kind, reversible, orally active MAT2A allogeneic inhibitor IC50 The value is 14 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: IDE397, GSK-4362676; MAT2A-IN-9 supplier, Methionine Adenosyltransferase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.